Source:http://linkedlifedata.com/resource/pubmed/id/17723304
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
2007-9-17
|
pubmed:abstractText |
A series of 7beta-[2-(2-aminothiazol-4-yl)-2-(Z)-(carboxymethoxyimino)acetamido]cephalosporins bearing a 1-(substituted)-1H-pyrrolo[3,2-b]pyridinium group at C-3' position was synthesized and their in vitro antibacterial activities against Pseudomonas aeruginosa and other Gram-negative pathogens were evaluated. Among the cephalosporins prepared, 7beta-[2-(2-amino-5-chlorothiazol-4yl)-2(Z)-((S)-1-carboxyethoxyimino)acetamido]cephalosporins (42d) showed potent antibacterial activities against P. aeruginosa and other Gram-negative pathogens including the strains which produce class C beta-lactamase and extended spectrum beta-lactamase (ESBL). These results imply that both the Cl atom on the C-7 aminothiazole moiety and the alpha-substituent at the iminoether moiety are essential for the stability against beta-lactamase and the potent activity against Gram-negative bacteria including P. aeruginosa.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6716-32
|
pubmed:meshHeading |
pubmed-meshheading:17723304-Anti-Bacterial Agents,
pubmed-meshheading:17723304-Cephalosporins,
pubmed-meshheading:17723304-Drug Administration Routes,
pubmed-meshheading:17723304-Gram-Negative Bacteria,
pubmed-meshheading:17723304-Humans,
pubmed-meshheading:17723304-Pseudomonas aeruginosa,
pubmed-meshheading:17723304-Structure-Activity Relationship
|
pubmed:year |
2007
|
pubmed:articleTitle |
A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships.
|
pubmed:affiliation |
Discovery Research Laboratories, Shionogi & Co Ltd, 12-4, Sagisu 5-Chome, Osaka, Japan. kenji.yamawaki@shionogi.co.jp
|
pubmed:publicationType |
Journal Article
|